Pricing Log in Create free account
Friday 6 November 2026 Export TEVA’s income statement to Excel — free account

Teva Pharmaceutical Industries Ltd.

TEVA Healthcare Drug Manufacturers Specialty & Generic

Teva Pharmaceutical Industries Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $17.3 billion, up 4.32% from fiscal 2024.

Revenue
−1.90%
EPS
−47.2%
Free cash flow
−30.3%
Total debt
−0.43%

Quarter to September 2026, against a year earlier

41.73 0.12 −0.29%
Market cap
$48.7B
P/E
92.6×
Fwd P/E
30.7×
Dividend yield
—
F-score
8/9
Altman Z
0.79
Beneish M
−2.35
Dividend safety
52/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Teva Pharmaceutical Industries Ltd. (TEVA) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, Teva Pharmaceutical Industries Ltd. (TEVA) trades at a EV/Sales of 3.6×. Over the past ten years it has ranged from 1.8× (October 2023) to 3.9× (September 2016); the current reading is higher than 99% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of 2.9× and in line with the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 2.8× 19.16%
FY2024 2.4× 32.23%
FY2023 1.8× (7.25%)
FY2022 1.9× 1.41%
FY2021 1.9× (7.01%)
FY2020 2.1× (2.37%)
FY2019 2.1× (10.11%)
FY2018 2.3× 12.37%
FY2017 2.1× (35.21%)
FY2016 3.2× 7.15%

Quarterly newest first

Period EV/Sales Change
Sep 2026 3.4× 12.76%
Jun 2026 3.0× 10.07%
Mar 2026 2.7× (3.13%)
Dec 2025 2.8× 26.12%
43 more quarters

Against its own ten years

Low 1.8× High 3.9×
Ten-year median 2.2×
Current reading's percentile 99

EV/Sales against peers

Company EV/Sales
VTRS Viatris Inc. compare 2.3×
HLN Haleon PLC Sponsored ADR compare 2.9×
ELAN Elanco Animal Health Incorporated compare 3.0×
TAK Takeda Pharmaceutical Co. compare 3.1×
TEVA Teva Pharmaceutical Industries Ltd. 3.6×
RDY Dr. Reddy's Laboratories Ltd compare 3.6×
NBIX Neurocrine Biosciences, Inc. compare 4.4×
ZTS Zoetis Inc. compare 4.5×
UTHR United Therapeutics Corporation compare 6.6×
Drug Manufacturers Specialty & Generic industry median 2.9×
Healthcare sector median 3.5×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on TEVA